ANAB Competitors & Alternatives
Compare AnaptysBio Inc with similar stocks in the same industry
Biotechnology
ANAB
Main Stock$57.74
Tradestie Score
48
Market Cap
$894.30M
Revenue Growth
-0.1%
Analyst Upside
+50.8%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.32
|
$1.78B | - | 40 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$26.10
|
$1.78B | - | 52 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$24.29
|
$1.74B | - | 37 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$40.38
|
$1.68B | - | 50 | Compare |
|
MNKD
Mannkind Corporation
|
$4.15
|
$1.65B | - | 52 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$44.18
|
$1.63B | - | 50 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.85
|
$1.57B | - | 49 | Compare |
|
VCEL
Vericel Corporation
|
$42.68
|
$1.56B | 87.7 | 53 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$111.10
|
$1.55B | - | 42 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$38.15
|
$1.55B | 12.9 | 49 | Compare |
More ANAB Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry